186 related articles for article (PubMed ID: 9568504)
1. Immunoperoxidase staining for cytokeratins 8 and 18 is very sensitive for detection of occult node metastasis of colorectal cancer: a comparison with genetic analysis of K-ras.
Sasaki M; Watanabe H; Jass JR; Ajioka Y; Kobayashi M; Hatakeyama K
Histopathology; 1998 Mar; 32(3):199-208. PubMed ID: 9568504
[TBL] [Abstract][Full Text] [Related]
2. Genetic diagnosis of lymph-node metastasis in colorectal cancer.
Hayashi N; Ito I; Yanagisawa A; Kato Y; Nakamori S; Imaoka S; Watanabe H; Ogawa M; Nakamura Y
Lancet; 1995 May; 345(8960):1257-9. PubMed ID: 7746054
[TBL] [Abstract][Full Text] [Related]
3. Genetic detection of colorectal cancer cells in circulation and lymph nodes.
Nakamori S; Kameyama M; Furukawa H; Takeda O; Sugai S; Imaoka S; Nakamura Y
Dis Colon Rectum; 1997 Oct; 40(10 Suppl):S29-36. PubMed ID: 9378009
[TBL] [Abstract][Full Text] [Related]
4. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node-negative" colorectal cancer.
Sasaki M; Watanabe H; Jass JR; Ajioka Y; Kobayashi M; Matsuda K; Hatakeyama K
J Gastroenterol; 1997 Dec; 32(6):758-64. PubMed ID: 9430013
[TBL] [Abstract][Full Text] [Related]
5. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
[TBL] [Abstract][Full Text] [Related]
6. Peptide nucleic acid clamp PCR: a novel K-ras mutation detection assay for colorectal cancer micrometastases in lymph nodes.
Taback B; Bilchik AJ; Saha S; Nakayama T; Wiese DA; Turner RR; Kuo CT; Hoon DS
Int J Cancer; 2004 Sep; 111(3):409-14. PubMed ID: 15221969
[TBL] [Abstract][Full Text] [Related]
7. Keratin 20 is a specific marker of submicroscopic lymph node metastases in colorectal cancer: validation by K-RAS mutations.
Yun K; Merrie AE; Gunn J; Phillips LV; McCall JL
J Pathol; 2000 May; 191(1):21-6. PubMed ID: 10767714
[TBL] [Abstract][Full Text] [Related]
8. Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method.
Hayashi N; Arakawa H; Nagase H; Yanagisawa A; Kato Y; Ohta H; Takano S; Ogawa M; Nakamura Y
Cancer Res; 1994 Jul; 54(14):3853-6. PubMed ID: 8033106
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma.
Niedergethmann M; Rexin M; Hildenbrand R; Knob S; Sturm JW; Richter A; Post S
Am J Surg Pathol; 2002 Dec; 26(12):1578-87. PubMed ID: 12459624
[TBL] [Abstract][Full Text] [Related]
10. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival.
Greenson JK; Isenhart CE; Rice R; Mojzisik C; Houchens D; Martin EW
Cancer; 1994 Feb; 73(3):563-9. PubMed ID: 7507795
[TBL] [Abstract][Full Text] [Related]
11. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
12. Tumor Budding Detection by Immunohistochemical Staining is Not Superior to Hematoxylin and Eosin Staining for Predicting Lymph Node Metastasis in pT1 Colorectal Cancer.
Okamura T; Shimada Y; Nogami H; Kameyama H; Kobayashi T; Kosugi S; Wakai T; Ajioka Y
Dis Colon Rectum; 2016 May; 59(5):396-402. PubMed ID: 27050601
[TBL] [Abstract][Full Text] [Related]
13. Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study.
Ahrendt SA; Yang SC; Wu L; Roig CM; Russell P; Westra WH; Jen J; Brock MV; Heitmiller RF; Sidransky D
J Thorac Cardiovasc Surg; 2002 Mar; 123(3):466-73; discussion 473-4. PubMed ID: 11882817
[TBL] [Abstract][Full Text] [Related]
14. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
15. Detection of occult metastases in sentinel lymph nodes from colon cancer patients by K-ras mutation peptide nucleic acid clamp PCR.
Oltedal S; Gilje B; Kørner H; Aasprong OG; Tjensvoll K; Heikkilä R; Smaaland R; Nordgård O
Ann Surg; 2010 Jun; 251(6):1087-91. PubMed ID: 20485143
[TBL] [Abstract][Full Text] [Related]
16. Detection of mutated K12-ras in histologically negative lymph nodes as an indicator of poor prognosis in stage II colorectal cancer.
Belly RT; Rosenblatt JD; Steinmann M; Toner J; Sun J; Shehadi J; Peacock JL; Raubertas RF; Jani N; Ryan CK
Clin Colorectal Cancer; 2001 Aug; 1(2):110-6. PubMed ID: 12445369
[TBL] [Abstract][Full Text] [Related]
17. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival.
Gu CD; Osaki T; Oyama T; Inoue M; Kodate M; Dobashi K; Oka T; Yasumoto K
Ann Surg; 2002 Jan; 235(1):133-9. PubMed ID: 11753052
[TBL] [Abstract][Full Text] [Related]
18. Genetic detection of lymph node micrometastases: a selection criterion for liver transplantation in patients with liver metastases after colorectal cancer.
Kappel S; Kandioler D; Steininger R; Längle F; Wrba F; Ploder M; Berlakovich G; Soliman T; Hetz H; Rockenschaub S; Roth E; Mühlbacher F
Transplantation; 2006 Jan; 81(1):64-70. PubMed ID: 16421478
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of lateral lymph node micrometastases in lower rectal cancer: an immunohistochemical study with CAM5.2.
Shimoyama M; Yamazaki T; Suda T; Hatakeyama K
Dis Colon Rectum; 2003 Mar; 46(3):333-9. PubMed ID: 12626908
[TBL] [Abstract][Full Text] [Related]
20. Can the One-Step Nucleic Acid Amplification method of lymph nodes examination make the staging of pulmonary tumours more precise?
Vodička J; Vejvodová Š; Pešta M; Mukenšnabl P; Špidlen V; Kulda V; Houfková K; Topolčan O
Rozhl Chir; 2018; 97(8):373-378. PubMed ID: 30441990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
